Your browser doesn't support javascript.
loading
A non-hallucinogenic psychedelic analogue with therapeutic potential.
Cameron, Lindsay P; Tombari, Robert J; Lu, Ju; Pell, Alexander J; Hurley, Zefan Q; Ehinger, Yann; Vargas, Maxemiliano V; McCarroll, Matthew N; Taylor, Jack C; Myers-Turnbull, Douglas; Liu, Taohui; Yaghoobi, Bianca; Laskowski, Lauren J; Anderson, Emilie I; Zhang, Guoliang; Viswanathan, Jayashri; Brown, Brandon M; Tjia, Michelle; Dunlap, Lee E; Rabow, Zachary T; Fiehn, Oliver; Wulff, Heike; McCorvy, John D; Lein, Pamela J; Kokel, David; Ron, Dorit; Peters, Jamie; Zuo, Yi; Olson, David E.
Afiliação
  • Cameron LP; Neuroscience Graduate Program, University of California, Davis, Davis, CA, USA.
  • Tombari RJ; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Lu J; Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Pell AJ; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Hurley ZQ; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Ehinger Y; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Vargas MV; Neuroscience Graduate Program, University of California, Davis, Davis, CA, USA.
  • McCarroll MN; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
  • Taylor JC; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
  • Myers-Turnbull D; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
  • Liu T; Quantitative Biosciences Consortium, University of California, San Francisco, San Francisco, CA, USA.
  • Yaghoobi B; Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Laskowski LJ; Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.
  • Anderson EI; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Zhang G; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Viswanathan J; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Brown BM; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Tjia M; Department of Pharmacology, School of Medicine, University of California, Davis, Davis, CA, USA.
  • Dunlap LE; Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Rabow ZT; Department of Chemistry, University of California, Davis, Davis, CA, USA.
  • Fiehn O; West Coast Metabolomics Center, University of California, Davis, Davis, CA, USA.
  • Wulff H; West Coast Metabolomics Center, University of California, Davis, Davis, CA, USA.
  • McCorvy JD; Department of Pharmacology, School of Medicine, University of California, Davis, Davis, CA, USA.
  • Lein PJ; Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Kokel D; Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.
  • Ron D; Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA.
  • Peters J; Department of Physiology, University of California, San Francisco, San Francisco, CA, USA.
  • Zuo Y; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Olson DE; Department of Anesthesiology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Nature ; 589(7842): 474-479, 2021 01.
Article em En | MEDLINE | ID: mdl-33299186

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Comportamento Aditivo / Ibogaína Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Comportamento Aditivo / Ibogaína Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article